Cliff Asness's PLSE Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 8,566 shares of Pulse Biosciences, Inc. (PLSE) worth $237,535, representing 0.00% of the portfolio. First purchased in 2017-Q2, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in PLSE, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2017, adding 24,432 shares. Largest reduction occurred in Q4 2018, reducing 17,309 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Pulse Biosciences (PLSE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pulse Biosciences (PLSE) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +8,566 | New Buy | 8,566 | $27.73 |
| Q2 2025 | -10,162 | Sold Out | 0 | $0.00 |
| Q1 2025 | -505 | Reduce 4.73% | 10,162 | $16.09 |
| Q4 2024 | +10 | Add 0.09% | 10,667 | $17.41 |
| Q3 2024 | -538 | Reduce 4.81% | 10,657 | $17.54 |
| Q2 2024 | -1,766 | Reduce 13.63% | 11,195 | $11.19 |
| Q1 2024 | +12,961 | New Buy | 12,961 | $8.71 |
| Q4 2018 | -17,309 | Sold Out | 0 | $0.00 |
| Q3 2018 | -15,227 | Reduce 46.80% | 17,309 | $14.21 |
| Q2 2018 | -17,176 | Reduce 34.55% | 32,536 | $15.15 |
| Q1 2018 | +6,358 | Add 14.67% | 49,712 | $13.54 |
| Q4 2017 | +24,432 | Add 129.12% | 43,354 | $23.60 |
| Q3 2017 | +10,565 | Add 126.42% | 18,922 | $18.60 |
| Q2 2017 | +8,357 | New Buy | 8,357 | $34.58 |
Cliff Asness's Pulse Biosciences Investment FAQs
Cliff Asness first purchased Pulse Biosciences, Inc. (PLSE) in Q2 2017, acquiring 8,357 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Pulse Biosciences, Inc. (PLSE) for 14 quarters since Q2 2017.
Cliff Asness's largest addition to Pulse Biosciences, Inc. (PLSE) was in Q4 2017, adding 43,354 shares worth $1.02 M.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 8,566 shares of Pulse Biosciences, Inc. (PLSE), valued at approximately $237,535.
As of the Q2 2026 filing, Pulse Biosciences, Inc. (PLSE) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Pulse Biosciences, Inc. (PLSE) was 49,712 shares, as reported at the end of Q1 2018.